The very article you're commenting on directly contradicts what you're saying. Big pharma is actively running studies and trying to get this fast tracked for treatment in the US and Europe.
Granted the article is somewhat poor reporting because the title should read "esketamine" not ketamine.
[1] http://slatestarcodex.com/2014/06/15/fish-now-by-prescriptio...
This is incorrect.
There are ongoing phase 3 clinical trials for nasally applied esketamine that will lead to FDA approval if succesfully reviewed. These trials are conducted worldwide and are very encouraging. The specific application seems to be patentable. First results should be available around 2019ish or 2020.
You can find the trials here:
https://clinicaltrials.gov/ct2/results?term=esketamine+depre...
And one of the patent applications here:
Specifically esketamine, not ketamine, because focusing on this specific isomer was the only way to get a new patent.
What if racemic ketamine performs better than esketamine? We'll never know because they won't test that.
It's quite likely some public institutions (e.g., universities, public research labs, etc.) or other countries (e.g., in India, China) will test exactly that. It's also in their interest to pubblish the results. So we'll get to know the differences between racemic ketamine, esketamine and arketamine.
The question is if different variants will also be approved, which is much more expensive.
http://www.maps.org/news/media/7082-press-release-maps-compl...
I get the feeling this is not a Gates kind of philanthropist, lol.
If said cost applies to only some of the employees, the employer won't have much in the way of even indirect incentives.
Why not? Probably need about $25M - $50M
Also Ketamine seems to be pallative vs. a cure, if I'm not mistaken.
Get 50 of those to each chip in $1 mill - it's pocket-change to them.
And this interest isn't completely fruitless just because the pharma industry will never support it. Individuals (admittedly, only those who can afford it) can still try to benefit from e.g. off-license prescriptions.
I would think given compelling enough research that there would be plenty of private foundation dollars to complete trials.
Well, it would be interesting to look at impartial cost/efficiency research regarding "health inspections". I routinely travel to countries where those inspections are just a pure formality, or completely non-existent - and, I must say, in most cases there's no trouble finding a good, safe place to eat.
Just because a thing exists (the FDA or taxes for instance), doesn't make it a good thing.
The public interest is for medical treatments to have the following qualities: safe, effective, affordable. The business interest for healthcare providers is for medical treatments to have the following property: profitable. Those interests only partially overlap.
It is possible to imagine many different institutional architectures that cater to the public's interests, and a large number of them are theoretically better than the actual results yielded from the FDA and the rest of the modern American health care system.
Thus, one of the consequences of maintaining the status quo is the foregone advantage of moving to a different and wholly incompatible system. That's the kind of argument only an economist could love, because it ties your brain up in knots trying to figure it out, and you can plausibly justify any prejudicial opinion you might care to support.
Yes, but the burden of proof lies with those who prefer an alternative. If you want to demonstrate an alternative is better, you need an honest and in depth comparison with the current. Just saying "the current sucks" isn't an argument.
I do agree it is difficult for drugs like ketamine, psilocybin, and MDMA(/MDA/MDE/etc) to get research funding, but that doesn't mean the current options are useless; we know they are useful, just not in every case. Nor does it mean that those mentioned drugs are better; we do not know.
That burden of proof lay originally with those that introduced, e.g., the FDA. We could go back to investigate whether we find that proof sufficient, if any was even provided, but your interpretation of the proof would perhaps be different than mine.
But decisions like creating an FDA are not based on proof, I would argue. It is based on other factors, especially on what can give government more power and what people will vote for. The average voter does not investigate any proof on the matter, but instead rely solely on gut feeling, for instance the feeling that drug companies are greedy enough to deliberately release drugs they know will harm people.
You can't set up an alternative to the FDA in order to test it, because the FDA is the supreme dictator over the regulatory domain, and you can't get around Mom saying "no" by asking Dad behind her back.
You can, however, look at the European pharmaceuticals regime, and note that an identical drug costs three times in the US the amount it costs in France.
Clearly, the FDA is not optimal. Equally clearly, we do not demand meta-studies proving that the FDA itself is safe and effective for its stated purpose.
I'm still anarchist in 2018, but I haven't been anywhere near the an-cap territory of it since around 2006. Sticking to a political dogma out in the libertarian hinterlands is really only good for pointlessly arguing with other libertarians on the Internet.
That can be fun sometimes, but it's not as entertaining as it used to be, what with everyone pointing at Twitler and saying "You see? This is exactly as (insert libertarian variant) predicted!"
How do you imagine abolishing the FDA would improve outcomes instead of increasing supplies (and marketing) of snake oil?
Can you prove that FDA improves the outcome? Is FDA somehow free from lobbying, or are the people working there consistently uninfluenced by certain counterproductive incentives? How could we go about ever proving that the absence or existence of a government agency has improved conditions overall? Sorry if this comes off as lecturing, but these are questions that I think should be asked and is not intended for you specifically.
In any case, you cannot take away that FDA approval likely costs millions of dollars and makes it more costly to introduce a drug. It is self-evident that making something more expensive to do reduces the incentive to do it (weighed against the potential profit).
No argument - but you didn't answer my questions at all other than to say "FDA is fallible!"
I can't prove the FDA is non-evil/non-fallible. I don't have numbers to share, so I'm going off of very fallible impressions. However, those impressions are that the FDA has done a better job of keeping crappy products off the market than a free-market world.
You complain about the opposite - good products being prevented because of lack of incentives. It's impossible to measure what hasn't happened, but do we have evidence that lack of incentive cause more harm than preventing crap/toxic/poisonous products that we have a recorded history of?
We have a solution today, a solution with problems, but a solution that I'm confident is better than the original problem. What is your basis to claim that removing the solution will in fact be better than the problem?
But Vitamin D is not patent protected and it's dirt cheap, so not only does Big Pharma have no interest in promoting it, but it would rather you take much more dangerous drugs and much more expensive drugs to cure the same things Vitamin D does.
This is what a private healthcare system gets you, where profit is always a bigger priority than the well-being of the patient.
This is a very odd comment thread. Lots of people criticizing our health system for not studying things it actually does study a lot.
The reason this treatment isn't mainstream isn't because "the research is still out" (though that may still be). It's because there are no financial interests to get it over the hoops into the highly convoluted state that enables affordable medical care.